Overview

A Study of Gaboxadol in Primary Insomnia

Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy safety and tolerability of gaboxadol in primary insomnia.
Phase:
Phase 3
Details
Lead Sponsor:
H. Lundbeck A/S
Treatments:
Gaboxadol